Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Lower costs with ambulatory fludrocortisone suppression test vs. in-patient testing
Ambulatory fludrocortisone suppression testing for primary aldosteronism has similar accuracy compared with in-patient fludrocortisone suppression testing but with significantly lower health care costs, according to study data.
Insulin resistance helps explain BP rise due to arterial stiffness in adolescents
Reducing insulin resistance may help lower BP in adolescents and young adults, according to a study published in Frontiers in Cardiovascular Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Assess CVD risk when considering hormone therapy for menopause symptoms
RANCHO PALOS VERDES, Calif. — Menopausal hormone therapy can help alleviate severe vasomotor symptoms, but cardiologists should assess CV risk and consider several other factors when evaluating these patients, according to a speaker.
Cumulative systolic BP load may improve CV prognostic value vs. other BP measures
Cumulative systolic BP load demonstrated improved prognostic value compared with other BP measures for the assessment of CV risk in patients with diabetes, according to data published in the Journal of the American College of Cardiology.
VIDEO: Racial, ethnic disparities in women’s cardiometabolic health must be reduced
RANCHO PALOS VERDES, Calif. — In this Healio video exclusive, a speaker at the Cardiometabolic Health Congress Women’s Cardiometabolic Health and Wellness Masterclass discusses racial and ethnic disparities in cardiometabolic health.
Cases of acute cholecystitis linked to GLP-1 receptor agonist use in US
Researchers have found 36 cases of acute cholecystitis associated with the use of GLP-1 receptor agonists in the U.S., according to findings from the FDA Adverse Event Reporting System published in JAMA Internal Medicine.
Focus on cardiometabolic health across the lifespan at upcoming CMHC women’s masterclass
The Cardiometabolic Health Congress’ Women’s Cardiometabolic Health and Wellness Masterclass will be held Sep. 9 to 11 in Rancho Palos Verdes, California.
Finerenone receives updated label to include data from patients with CKD, diabetes
Bayer has received FDA approval to update to the label for finerenone, a nonsteroidal mineralocorticoid receptor antagonist, according to a press release.
Short-term NSAID use may increase risk for first-time HF hospitalization in diabetes
An analysis of Danish registry data show that NSAID use, even for a short time, could raise risk for new-onset HF hospitalization among adults with type 2 diabetes, researchers reported at the European Society of Cardiology Congress.
Risk for kidney function loss elevated for African Caribbean adults with type 1 diabetes
African Caribbean adults with type 1 diabetes have a higher risk for kidney function loss than those of other ethnicities, according to study findings published in Diabetes Care.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read